Retrospective Study
Copyright ©The Author(s) 2020.
World J Gastrointest Oncol. Nov 15, 2020; 12(11): 1325-1335
Published online Nov 15, 2020. doi: 10.4251/wjgo.v12.i11.1325
Figure 1
Figure 1 Survival curves of 117 patients according to the independent prognostic factors. A: Subtotal vs total gastrectomy; B: Subtotal vs total gastrectomy (lower-middle lesions); C: Lymph node status (pN stage); D: Tumor invasion depth (pT stage); E: Postoperative chemotherapy. pN: Lymph node status; pT: Tumor invasion depth.
Figure 2
Figure 2 Survival curves of chemotherapy for different Borrmann type IV patients. A: Patients with subtotal gastrectomy; B: Patients with total gastrectomy; C: Patients of different ages.
Figure 3
Figure 3 Mean survival and 3-yr overall survival rates of different groups of 117 patients according to Cox multivariate analysis. TG: Total gastrectomy; STG: Subtotal gastrectomy; LNM: Lymph node metastasis; Chemo: Chemotherapy; MS: Median survival (mo); OSR: Overall survival rate.